₹ 1,597.90
84.30 (5.57%)
S
Symbiotec Pharmalab
₹ 1,597.90
SYMBIOTEC Financials Summary (Consolidated)
Symbiotec Pharmalab revenue increased 28.15% quarter-on-quarter to ₹280 Cr in Sep 2026, while net profit increased 266.67% quarter-on-quarter to ₹52 Cr. Compared to the same quarter last year, revenue is up 43.08% and net profit is up 169.27%. EPS for the quarter stood at ₹8.20, increased from ₹2.24 in the previous quarter and up from ₹3.45 a year ago.
Symbiotec Pharmalab Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of SYMBIOTEC Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
SYMBIOTEC Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

